TRIEU VUONG (CEO and Chairman of the Board) purchased 0.4% of their position (400K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $13.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/16/2023ACC: 0001493152-23-021563
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+400K
Net shares
Net buyer
$13.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
400K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+400K
Price / share
$0.03
Trade value
$13.04K
% of position
0.4%
6/14/2023
91.04M→91.44M
Total
Net shares
+400K
Net value
$13.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/14/2023 | P · Purchase | +400K | $0.03 | $13.04K | 0.4% | 91.04M | 91.44M |
| Total | +400K | $13.04K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned16.78M
Common Stock
IndirectShares owned6.87M
Total
23.65M indirect23.65M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 16.78M | Indirect |
| Common Stock | 6.87M | Indirect |
| Total | 23.65M | 23.65M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported